HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miriam Adelson Selected Research

Heroin Dependence (Heroin Abuse)

1/2021Polymorphisms in Stress-Related Genes Are Associated with Reduced Cocaine Abuse and Longer Retention in Methadone Maintenance Treatment for Opioid Use Disorder.
1/2018A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction.
1/2018Genetic variations in genes of the stress response pathway are associated with prolonged abstinence from heroin.
1/2016Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry.
1/2016African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction.
11/2015Synaptic Plasticity and Signal Transduction Gene Polymorphisms and Vulnerability to Drug Addictions in Populations of European or African Ancestry.
5/2015Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.
7/2014Drug addiction and stress-response genetic variability: association study in African Americans.
7/2008ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Miriam Adelson Research Topics

Disease

26Opioid-Related Disorders (Opiate Addiction)
04/2024 - 02/2005
14Substance-Related Disorders (Drug Abuse)
12/2020 - 02/2005
13Hepatitis C
01/2023 - 01/2004
11Cocaine-Related Disorders (Cocaine Addiction)
01/2021 - 01/2006
9Mental Disorders (Mental Disorder)
01/2023 - 08/2003
9Heroin Dependence (Heroin Abuse)
01/2021 - 07/2008
7Chronic Pain
09/2016 - 02/2005
7Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
09/2016 - 07/2009
6Pain (Aches)
07/2021 - 02/2005
5Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2016 - 01/2012
4Weight Gain
04/2024 - 10/2016
4Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2021 - 09/2014
3Communicable Diseases (Infectious Diseases)
07/2015 - 01/2006
3Gambling (Pathological Gambling)
12/2014 - 07/2009
2Cognitive Dysfunction
01/2019 - 12/2014
2Alcoholism (Alcohol Abuse)
01/2018 - 11/2015
2Birth Weight (Birth Weights)
03/2017 - 03/2012
2Genetic Predisposition to Disease (Genetic Predisposition)
05/2015 - 01/2015
2Wounds and Injuries (Trauma)
09/2014 - 01/2012
2Hepatitis B
03/2010 - 01/2007
1Hypertension (High Blood Pressure)
04/2024
1Psychotic Disorders (Schizoaffective Disorder)
04/2022
1Schizophrenia (Dementia Praecox)
04/2022
1Constipation
01/2021
1Acquired Immunodeficiency Syndrome (AIDS)
01/2020
1Overweight
01/2018
1Weight Loss (Weight Reduction)
01/2018
1Sleepiness
01/2017
1Hyperalgesia
09/2016
1Long QT Syndrome
11/2013
1Dissociative Identity Disorder (Multiple Personalities)
12/2012
1Infections
09/2011
1Neoplasms (Cancer)
03/2010
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
07/2008
1Torsades de Pointes (Torsade de Pointes)
02/2007
1Sleep Wake Disorders
04/2006
1Marijuana Abuse (Cannabis Abuse)
01/2004

Drug/Important Bio-Agent (IBA)

472-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
04/2024 - 01/2004
46Methadone (Dolophine)FDA LinkGeneric
04/2024 - 08/2003
18BenzodiazepinesIBA
01/2023 - 01/2006
10Opiate AlkaloidsIBA
01/2018 - 01/2007
10Heroin (Diamorphine)IBA
01/2016 - 02/2007
9Cocaine (Cocaine HCl)IBA
11/2019 - 04/2007
5Opioid Analgesics (Opioids)IBA
01/2023 - 02/2011
2Pregabalin (Lyrica)FDA Link
07/2021 - 01/2018
2Carrier Proteins (Binding Protein)IBA
01/2021 - 11/2019
2Analgesics (Analgesic Drugs)IBA
01/2021 - 01/2011
2Long Noncoding RNAIBA
01/2019 - 01/2018
2Dronabinol (THC)FDA LinkGeneric
01/2008 - 04/2007
2AmphetaminesIBA
01/2008 - 04/2007
1delta Opioid Receptors (delta Opioid Receptor)IBA
01/2023
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2023
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021
1VitaminsIBA
01/2021
1Vitamin DFDA LinkGeneric
01/2021
1Adrenocorticotropic Hormone (ACTH)FDA Link
11/2019
1Hormones (Hormone)IBA
11/2019
13' Untranslated Regions (3' UTR)IBA
01/2019
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2018
1Buprenorphine (Subutex)FDA LinkGeneric
03/2017
15-methoxy-methylindoleacetic acid (DBI)IBA
01/2016
1Glutamic Acid (Glutamate)FDA Link
01/2016
1gamma-Aminobutyric Acid (GABA)IBA
01/2016
1Cholinergic ReceptorsIBA
01/2016
1Genetic Markers (Genetic Marker)IBA
01/2016
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2016
1Muscarinic M4 ReceptorIBA
01/2016
1Monoamine Oxidase (MAO)IBA
01/2016
1Neurotensin Receptors (Neurotensin Receptor)IBA
11/2015
1Proteins (Proteins, Gene)FDA Link
11/2015
1Amphetamine (Amfetamine)FDA LinkGeneric
07/2015
1Methylphenidate (Ritalin)FDA LinkGeneric
07/2015
1Dopamine (Intropin)FDA LinkGeneric
05/2015
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2015
1N-sulfo-2-aminotricarballylate (SATC)IBA
09/2014
1Galanin Receptors (Galanin Receptor)IBA
07/2014
1Oxytocin Receptors (Oxytocin Receptor)IBA
07/2014
1HIV AntibodiesIBA
01/2014
1Potassium Channels (Potassium Channel)IBA
11/2013
1Cytochrome P-450 CYP2B6 (CYP2B6)IBA
07/2013
1NicotineFDA Link
01/2012
1Pain-FreeIBA
01/2011
1mu Opioid Receptors (mu Opioid Receptor)IBA
07/2008
1Amitriptyline (Elavil)FDA LinkGeneric
03/2008
1benzoylecgonineIBA
04/2007
1Hepatitis B AntigensIBA
01/2007

Therapy/Procedure

1Precision Medicine
01/2021
1Reducing Diet
01/2018
1Self Medication
07/2015
1Duration of Therapy
12/2014
1Therapeutics
11/2013
1Analgesia
02/2011